Elizabeth Mazzio to Breast Neoplasms
This is a "connection" page, showing publications Elizabeth Mazzio has written about Breast Neoplasms.
Connection Strength
0.716
-
Mazzio EA, Lewis CA, Elhag R, Soliman KF. Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response. Cancer Genomics Proteomics. 2018 Jul-Aug; 15(4):249-264.
Score: 0.292
-
Mazzio E, Badisa R, Mack N, Deiab S, Soliman KF. High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cells. Phytother Res. 2014 Jun; 28(6):856-67.
Score: 0.210
-
Bauer D, Mazzio E, Soliman KFA. Whole Transcriptomic Analysis of Apigenin on TNFa Immuno-activated MDA-MB-231 Breast Cancer Cells. Cancer Genomics Proteomics. 2019 Nov-Dec; 16(6):421-431.
Score: 0.080
-
Bauer D, Redmon N, Mazzio E, Soliman KF. Apigenin inhibits TNFa/IL-1a-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells. PLoS One. 2017; 12(4):e0175558.
Score: 0.067
-
Mack N, Mazzio EA, Bauer D, Flores-Rozas H, Soliman KF. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival. Anticancer Res. 2017 03; 37(3):1205-1212.
Score: 0.067